ÂÜÀòÂÒÂ×

Jason Fewell has a strong background in scientific research and development. Jason is currently serving as the Chief Scientific Officer at transOMIC technologies inc. Their previous role was as the VP Preclinical Research at Celsion Corporation from June 2014 to February 2021. Before that, they held the position of VP Preclinical Research and Development at EGEN, Inc. from July 2003 to June 2014. Jason started their career as a Senior Scientist at GeneMedicine/Valentis in April 1998 and worked there until October 2002.

Jason Fewell holds a Ph.D. in Biological Science, which they obtained from Florida State University. Prior to that, they completed their undergraduate studies at the University of North Carolina Wilmington, where they earned a Bachelor of Science degree in Marine Biology.